Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone

Scandinavian Journal of Immunology

Volumn 45, Issue 6, 1997, Pages 605-612

  Wells, A D ^a,c,d   Rai, S K ^b   Salvato, M S ^b,d   Band, H ^e   Malkovsky, M ^a,c,d,f  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Laboratory Medicine   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 65; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031002389     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-436.x     Document Type: Article

References (35)

1. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76:287-99.
2. Shepherd JC, Schumacher TNM, Ashton-Rickardt PG et al. TAP1-dependent peptide translocation in vitro is ATP-dependent and peptide selective. Cell 1993;74:577-84.
3. Neefjes JJ, Momburg F, Hammerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993;261:769-71.
4. Restifo NP, Esquivel FA, Asher L et al. Defective presentation of endogenous antigens by a murine sarcoma. J Immunol 1991;147: 1453-9.
5. Restifo NP, Esquivel F, Kawakami Y et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-77.
6. Kaklamanis L, Leek R, Koukourakis M, Gatter KC, Harris AL. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res 1995;55:5191-4.
7. Williams DB, Watts TH. Molecular chaperones in antigen presentation. Curr Op Immun 1995;7:77-84.
8. Georgopoulos C, Welch W. Role of the major heat shock proteins as molecular chaperones. Ann Rev Cell Biol 1993;9:601-34.
9. Lukacs KV, Lowrie DB, Stokes RW, Colston MJ. Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors. J Exp Med 1993;178:343-8.
10. Shinnick TM. The 65-kilodalton antigen of Mycobacterium tuberculosis. J Bacteriol 1987;169:1080-8.
11. Bukowski JF, Morita C, Tanaka Y, Bloom BR, Brenner MB, Band H. V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995;154:998-1006.
12. Takebe Y, Seiki M, Fujisawa J-I et al. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol 1988;8:466-72.
13. Stallcup KC, Springer TA, Mescher MF. Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. J Immunol 1981;127:923-30.
14. Allen H, Wraith D, Pala P, Askonas B, Flavell RA. Domain interactions of H-2 class I antigen alter cytotoxic T-cell recognition sites. Nature 1984;309:279-82.
15. b haplo-type reveal genetic control of isotype expression. J Immunol 1981;126:317-22.
16. Eisenbraun MD, Fuller DH, Haynes JR. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol 1993;12:7918-27.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Press, 1991.
18. Malkovsky M, Asherson GL, Stockinger B, Watkins MC. Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature 1982;300:652-5.
19. Salvato M, Borrow P, Shimomaye E, Oldstone MB. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol 1991;65:1863-9.
20. Fidler I, Gersten P, Hart I. The biology of cancer invasion and metastasis. Adv Cancer Res 1978;28:149-250.
21. Nanni P, Colombo MP, De Giovanni C et al. Impaired H-2 expression in B16 melanoma variants. J Immunogenet 1983;10:361-70.
22. Kim ST, Cohen EP. MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens. Cancer Immun Immunother 1994;38:185-93.
23. Kuroda K, Yamashina K, Kitatani N, Kagishima A, Hamaoka T, Hosaka Y. Characterization of defectiveness in endogenous antigen presentation of novel murine cells established from methylcholanthrene-induced fibrosarcomas. Immunology 1995;84: 153-8.
24. Ljunggren HG, Karre K. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 1990;11:237-44.
25. Whitton JL, Gebhard JR, Lewicki H, Tishon A, Oldstone MB. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J Virol 1988;62:687-95.
26. b cytotoxic T lymphocytes. J Exp Med 1988;168: 559-64.
27. Townsend A, Ohlen C, Bastin J, Foster L, Karre K. Nature 1989;340:443-6.
28. Baas EJ, van Santen HM, Kleijmeer MJ, Geuze HJ, Peters PJ, Ploegh HL. Peptide-induced stabilization and intracellular localization of empty HLA class I complexes. J Exp Med 1992;176:147-56.
29. Rajagopalan S, Brenner M. Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum. J Exp Med 1994;180:407-12.
30. Langer T, Neupert W. Heat shock proteins hsp60 and hsp70: their roles in folding, assembly and membrane translocation of proteins. Curr Top Microbiol Immunol 1990;167:3-30.
31. Schirmbeck R, Reimann J. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 1994;24:1478-86.
32. Suto S, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995;269: 1585-8.
33. Arnold D, Faath S, Rammensee H-G, Schild H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995;182:885-9.
34. Pardoll DM. Cancer vaccines. Curr Op Immunol 1993;5:719-25.
35. Coughlin CM, Wysocka M, Kurzawa HL, Lee WMF, Trinchieri G, Eck SL. B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res 1995;55:4980-7.